3BNC117 Monoclonal Antibody in HIV-infected Subjects During Treatment Interruption

NCT02446847 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

16

Enrollment

OTHER

Sponsor class

Conditions

HIV-1 Infection

Interventions

DRUG: 3BNC117
OTHER: ART Interruption

Sponsor

Rockefeller University